Analysis of the sublingual microvascular glycocalyx in critically ill patients – a prospective observational study
Authors:
D. Astapenko 1,2; P. Dostál 1; R. Černá Pařízková 1; R. Škulec 3; V. Černý 1–4
Authors‘ workplace:
Klinika anesteziologie, resuscitace a intenzivní medicíny, Fakultní nemocnice Hradec Králové a Lékařská fakulta v Hradci Králové, Univerzita Karlova
; Centrum pro výzkum a vývoj, Fakultní nemocnice Hradec Králové
2; Klinika anesteziologie, perioperační a intenzivní medicíny, Univerzita J. E. Purkyně a Masarykova nemocnice v Ústí nad Labem, Institut postgraduálního vzdělávání ve zdravotnictví
3; Department of Anesthesia, Pain Management and Perioperative Medicine, Dalhousie University, Halifax, Kanada
4
Published in:
Anest. intenziv. Med., 30, 2019, č. 1, s. 14-21
Category:
Intensive Care Medicine - Original Paper
Overview
Objective: The endothelial glycocalyx (EG) plays a central role in the coupling functions of microcirculation and tissue metabolism. EG is particularly important in critically ill patients in whom it suffers damage. The aim of study was to describe the condition of EG in critically ill patients in dependence of the severity of the illness and the usage of various methods of organ support, using a non-invasive method assessment.
Design: Monocentric, prospective, observational study.
Setting: Intensive Care Unit (ICU) at a University Hospital.
Materials and methods: Adult patients admitted to the ICU with anticipated length of stay of at least 7 days were enrolled. Demographic and clinical data were recorded together with sublingual microcirculation recordings for Perfused Boundary Region (PBR) analysis.
Results: Total 40 patients were selected for the analysis. The median (IQR) baseline PBR was 1.97 μm (1.75-2.12). There was no significant difference in PBR at different time points. PBR poorly correlated with the APACHE II and SOFA scores. PBR was shown as a poor predictor of septic shock or positive fluid balance. PBR was significantly higher in patients with insidious onset of critical illness (p = 0.0038) and in patients with renal replacement therapy (CRRT) (p = 0.007).
Conclusion: The PBR parameter shows a high inter-individual variability and cannot be considered as a reliable method of assessment of EG damage in critically ill patients. PBR is not a suitable method for predicting clinical conditions such as sepsis or positive fluid balance. Higher PBR values were associated with the presence of septic shock, insidions onset of critical illness and CRRT.
Keywords:
endothelial glycocalyx – sublingual microcirculation – intensive care
Sources
1. Curry FE. Layer upon layer: the functional consequences of disrupting the glycocalyx-endothelial barrier in vivo and in vitro. Cardiovasc Res. 2017;113:559–561. doi:10.1093/cvr/cvx044.
2. Schött U, Solomon C, Fries D, Bentzer P. The endothelial glycocalyx and its disruption, protection and regeneration: a narrative review. Scand J Trauma Resusc Emerg Med. 2016;24:48. doi:10.1186/s13049-016-0239-y.
3. Nieuwdorp M, Meuwese MC, Vink H, Hoekstra JBL, et al. The endothelial glycocalyx: a potential barrier between health and vascular disease. Curr Opin Lipidol. 2005;16:507–511.
4. Mulivor AW, Lipowsky HH. Inflammation- and ischemia-induced shedding of venular glycocalyx. Am J Physiol Heart Circ Physiol. 2004;286:H1672–680. doi:10.1152/ajpheart.00832.2003.
5. Johansson PI, Henriksen HH, Stensballe J, et al. Traumatic Endotheliopathy: A Prospective Observational Study of 424 Severely Injured Patients. Ann Surg. 2016. doi:10.1097/SLA.0000000000001751.
6. Johansson P, Stensballe J, Ostrowski S. Shock induced endotheliopathy (SHINE) in acute critical illness - a unifying pathophysiologic mechanism. Crit Care. 2017;21:25. doi:10.1186/s13054-017-1605-5.
7. Donati A, Damiani E, Domizi R, et al. Alteration of the sublingual microvascular glycocalyx in critically ill patients. Microvasc Res. 2013. doi:10.1016/j.mvr.2013.08.007.
8. Rovas A, Lukasz A-H, Vink H, et al. Bedside analysis of the sublingual microvascular glycocalyx in the emergency room and intensive care unit – the GlycoNurse study. Scand J Trauma Resusc Emerg Med. 2018;26:16. doi:10.1186/s13049-018-0483-4.
9. Nussbaum C, Haberer A, Tiefenthaller A, et al. Perturbation of the microvascular glycocalyx and perfusion in infants after cardiopulmonary bypass. J Thorac Cardiovasc Surg. 2015;150:1474-1481.e1. doi:10.1016/j.jtcvs.2015.08.050.
10. Lee DH, Dane MJC, van den Berg BM, et al. Deeper penetration of erythrocytes into the endothelial glycocalyx is associated with impaired microvascular perfusion. PLoS One. 2014;9:e96477. doi:10.1371/journal.pone.0096477.
11. Chignalia AZ, Yetimakman F, Christiaans SC, et al. THE GLYCOCALYX AND TRAUMA. Shock. 2016;45:338–348. doi:10.1097/SHK.0000000000000513.
12. Schiefer J, Lebherz-Eichinger D, Erdoes G, et al. Alterations of Endothelial Glycocalyx During Orthotopic Liver Transplantation in Patients With End-Stage Liver Disease. Transplantation. 2015:1. doi:10.1097/TP.0000000000000680.
13. Ince C, Mayeux PR, Nguyen T, et al. THE ENDOTHELIUM IN SEPSIS. Shock. 2016;45:259–270. doi:10.1097/SHK.0000000000000473.
14. Tarbell JM, Cancel LM. The glycocalyx and its significance in human medicine. J Intern Med. 2016;280:97–113. doi:10.1111/joim.12465.
15. Kang H, Wu Q, Sun A, et al. Cancer Cell Glycocalyx and Its Significance in Cancer Progression. Int J Mol Sci. 2018;19:2484. doi:10.3390/ijms19092484.
16. Zhang X, Sun D, Song JW, et al. Endothelial cell dysfunction and glycocalyx – A vicious circle. Matrix Biol. 2018;71–72:421–431. doi:10.1016/j.matbio.2018.01.026.
17. Martens RJH, Vink H, van Oostenbrugge RJ, Staals J. Sublingual microvascular glycocalyx dimensions in lacunar stroke patients. Cerebrovasc Dis. 2013;35:451–454. doi:10.1159/000348854.
18. Donati A, Damiani E, Domizi R, et al. Alteration of the sublingual microvascular glycocalyx in critically ill patients. Microvasc Res. 2013;90:86–89. doi:10.1016/j.mvr.2013.08.007.
19. Rovas A, Lukasz A-H, Vink H, et al. Bedside analysis of the sublingual microvascular glycocalyx in the emergency room and intensive care unit – the GlycoNurse study. Scand J Trauma Resusc Emerg Med. 2018;26:16. doi:10.1186/s13049-018-0483-4.
20. Oberleithner H, Riethmüller C, Schillers H, et al. Plasma sodium stiffens vascular endothelium and reduces nitric oxide release. Proc Natl Acad Sci U S A. 2007;104:16281–16286. doi:10.1073/pnas.0707791104.
21. Oberleithner H, Peters W, Kusche-Vihrog K, et al. Salt overload damages the glycocalyx sodium barrier of vascular endothelium. Pflugers Arch. 2011;462:519–528. doi:10.1007/s00424-011-0999-1.
22. Chappell D, Bruegger D, Potzel J, et al. Hypervolemia increases release of atrial natriuretic peptide and shedding of the endothelial glycocalyx. Crit Care. 2014;18:538. doi:10.1186/s13054-014-0538-5.
23. Dogné S, Flamion B, Caron N. Endothelial Glycocalyx as a Shield Against Diabetic Vascular Complications. Arterioscler Thromb Vasc Biol. 2018;38:1427–1439. doi:10.1161/ATVBAHA.118.310839.
24. Godo S, Shimokawa H. Endothelial Functions. Arterioscler Thromb Vasc Biol. 2017;37:e108–e114. doi:10.1161/ATVBAHA.117.309813.
25. Myers GJ, Wegner J. Endothelial Glycocalyx and Cardiopulmonary Bypass. J Extra Corpor Technol. 2017;49:174–181. Available at: http://www.ncbi.nlm.nih.gov/pubmed/28979041. Accessed December 27, 2018.
26. Mitsides N, Cornelis T, Broers NJH, et al. Extracellular overhydration linked with endothelial dysfunction in the context of inflammation in haemodialysis dependent chronic kidney disease. Shimosawa T, ed. PLoS One. 2017;12:e0183281. doi:10.1371/journal.pone.0183281.
27. Vlahu CA, Lopes Barreto D, et al. Is the Systemic Microvascular Endothelial Glycocalyx in Peritoneal Dialysis Patients Related to Peritoneal Transport? Nephron Clin Pract. 2014;128:159–165. doi:10.1159/000368081.
28. Stancu CS, Toma L, Sima AV. Dual role of lipoproteins in endothelial cell dysfunction in atherosclerosis. Cell Tissue Res. 2012;349:433–446. doi:10.1007/s00441-012-1437-1.
29. Reitsma S, oude Egbrink M, Heijnen V, et al. Endothelial glycocalyx thickness and platelet-vessel wall interactions during atherogenesis. Thromb Haemost. 2011;106:939–946. doi:10.1160/TH11-02-0133.
30. Mitra R, O’Neil GL, Harding IC, et al. Glycocalyx in Atherosclerosis-Relevant Endothelium Function and as a Therapeutic Target. Curr Atheroscler Rep. 2017;19:63. doi:10.1007/s11883-017-0691-9.
31. Zeng Y, Liu X-H, Tarbell J, Fu B. Sphingosine 1-phosphate induced synthesis of glycocalyx on endothelial cells. Exp Cell Res. 2015;339:90–95. doi:10.1016/j.yexcr.2015.08.013.
32. Zeng Y, Adamson RH, Curry F-RE, Tarbell JM. Sphingosine-1-phosphate protects endothelial glycocalyx by inhibiting syndecan-1 shedding. Am J Physiol Circ Physiol. 2014;306:H363–H372. doi:10.1152/ajpheart.00687.2013.
33. Astapenko D, Dostalova V, Dostalova V jr., et al. Effect of acute hypernatremia induced by hypertonic saline administration on endothelial glycocalyx in rabbits. Clin Hemorheol Microcirc. 2018:1–10. doi:10.3233/CH-189907.
34. Cerny V, Astapenko D, Brettner F, et al. Targeting the endothelial glycocalyx in acute critical illness as a challenge for clinical and laboratory medicine. Crit Rev Clin Lab Sci. 2017;54:343–357. doi:10.1080/10408363.2017.1379943.
Labels
Anaesthesiology, Resuscitation and Inten Intensive Care MedicineArticle was published in
Anaesthesiology and Intensive Care Medicine
2019 Issue 1
Most read in this issue
- Clinical presentation and management of phantom pain
- Epidural analgesia in obstetrics
- Caudal block in adult patients and its use in the perioperative period
- Anaesthesia information management systems in the Czech Republic – Are they still just a calling of the future?